MarketPeel
Insider Trading Intelligence
Pricing
…
ON

Oleg Nodelman

NUVB
DIRECTOR · NUVATION BIO INC. · CIK 0001454385
FILING MIX · LIFETIME87%/13%
BUYS
67
SELLS
10
TOTAL VALUE
$153.25M
COMPANIES
4
ACTIVE SINCE
Feb 2021
HOLDINGS NOW
44,490,447
AVG SELL PX
$20.62
TRADE KIND
SHOWING 77 / 77
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
51 backtested trades · 8 horizons · 29 pending
Forward-return performance of every backtestable P/S trade by Oleg Nodelman, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d51+45.10%+0.35%-0.70%+1.05%-1.22%0.91
14d51+50.98%+1.33%-0.87%+2.20%+1.11%1.69
30d51+60.78%+1.05%-0.18%+1.23%+1.79%0.76
60d51+49.02%+4.44%+3.08%+1.36%-3.56%0.67
90d51+52.94%+0.62%+5.87%-5.24%-5.70%-2.42
180d51(2 pending)+69.39%+19.38%+11.31%+8.07%+8.91%2.27
1y51(2 pending)+63.27%+43.26%+14.05%+29.21%+65.32%3.03
2y51(25 pending)+30.77%-21.87%+16.78%-38.65%-47.42%—
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
NUVB · 12,674,775 shares · as of Sep 21, 2023
03,168,6946,337,3889,506,08112,674,77520222023SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
FLOW · 67 buys / 10 sellsCOVERAGE · 21 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
AKTS
AKTIS ONCOLOGY, INC.
SALE
102,500——0Jan 12, 2026Jan 12, 2026 ↗View →
AKTS
AKTIS ONCOLOGY, INC.
PURCHASE
86,222——86,222Jan 12, 2026Jan 12, 2026 ↗View →
AKTS
AKTIS ONCOLOGY, INC.
PURCHASE
2,077,779$18.00$37.40M4,348,658Jan 12, 2026Jan 12, 2026 ↗View →
AKTS
AKTIS ONCOLOGY, INC.
PURCHASE
144,443$18.00$2.60M347,305Jan 12, 2026Jan 12, 2026 ↗View →
AKTS
AKTIS ONCOLOGY, INC.
SALE
2,397,500——0Jan 12, 2026Jan 12, 2026 ↗View →
AKTS
AKTIS ONCOLOGY, INC.
PURCHASE
202,862——202,862Jan 12, 2026Jan 12, 2026 ↗View →
AKTS
AKTIS ONCOLOGY, INC.
PURCHASE
128,506——128,506Jan 12, 2026Jan 12, 2026 ↗View →
AKTS
AKTIS ONCOLOGY, INC.
SALE
488,891——0Jan 12, 2026Jan 12, 2026 ↗View →
AKTS
AKTIS ONCOLOGY, INC.
SALE
997,299——0Jan 12, 2026Jan 12, 2026 ↗View →
AKTS
AKTIS ONCOLOGY, INC.
PURCHASE
2,270,879——2,270,879Jan 12, 2026Jan 12, 2026 ↗View →
AKTS
AKTIS ONCOLOGY, INC.
SALE
9,913,810——0Jan 12, 2026Jan 12, 2026 ↗View →
AKTS
AKTIS ONCOLOGY, INC.
PURCHASE
965,190——965,190Jan 12, 2026Jan 12, 2026 ↗View →
ZYME
ZYMEWORKS INC.
PURCHASE
5,086,480$0.00$50922,970,388Jun 26, 2025Jun 27, 2025 ↗View →
ZYME
ZYMEWORKS INC.
SALE
5,086,521——0Jun 26, 2025Jun 27, 2025 ↗View →
ZYME
ZYMEWORKS INC.
SALE
41$12.71$52122,970,388Jun 26, 2025Jun 27, 2025 ↗View →
ZYME
ZYMEWORKS INC.
PURCHASE
5,919$11.78$69.7K17,883,908May 19, 2025May 19, 2025 ↗View →
ZYME
ZYMEWORKS INC.
PURCHASE
49,502$11.43$565.8K17,877,989May 15, 2025May 19, 2025 ↗View →
ZYME
ZYMEWORKS INC.
PURCHASE
54,760$11.52$630.8K17,828,487Apr 17, 2025Apr 18, 2025 ↗View →
ZYME
ZYMEWORKS INC.
PURCHASE
73,953$11.16$825.6K17,773,727Apr 16, 2025Apr 18, 2025 ↗View →
ZYME
ZYMEWORKS INC.
PURCHASE
196,438$11.17$2.19M17,699,774Apr 4, 2025Apr 7, 2025 ↗View →
ZYME
ZYMEWORKS INC.
PURCHASE
120,770$11.84$1.43M17,503,336Apr 3, 2025Apr 7, 2025 ↗View →
ZYME
ZYMEWORKS INC.
PURCHASE
74,360$11.85$881.0K17,382,566Apr 2, 2025Apr 2, 2025 ↗View →
ZYME
ZYMEWORKS INC.
PURCHASE
48,658$11.60$564.6K17,308,206Apr 1, 2025Apr 2, 2025 ↗View →
ZYME
ZYMEWORKS INC.
PURCHASE
4,397$11.75$51.7K17,259,548Mar 31, 2025Apr 2, 2025 ↗View →
ZYME
ZYMEWORKS INC.
PURCHASE
43,848$12.24$536.9K17,255,151Mar 26, 2025Mar 26, 2025 ↗View →
ZYME
ZYMEWORKS INC.
PURCHASE
53,501$12.91$690.5K17,211,303Mar 25, 2025Mar 26, 2025 ↗View →
ZYME
ZYMEWORKS INC.
PURCHASE
22,689$13.08$296.8K17,157,802Mar 24, 2025Mar 24, 2025 ↗View →
ZYME
ZYMEWORKS INC.
PURCHASE
31,033$12.78$396.5K17,135,113Mar 21, 2025Mar 24, 2025 ↗View →
ZYME
ZYMEWORKS INC.
PURCHASE
73,476$12.93$949.9K17,104,080Mar 20, 2025Mar 24, 2025 ↗View →
ZYME
ZYMEWORKS INC.
PURCHASE
58,306$12.64$737.2K17,030,604Mar 19, 2025Mar 19, 2025 ↗View →
ZYME
ZYMEWORKS INC.
PURCHASE
113,880$12.65$1.44M16,972,298Mar 18, 2025Mar 19, 2025 ↗View →
ZYME
ZYMEWORKS INC.
PURCHASE
56,277$12.23$688.5K16,858,418Mar 17, 2025Mar 19, 2025 ↗View →
ZYME
ZYMEWORKS INC.
PURCHASE
468,356$12.48$5.85M16,802,141Mar 13, 2025Mar 13, 2025 ↗View →
ZYME
ZYMEWORKS INC.
PURCHASE
292,934$12.25$3.59M16,333,785Mar 12, 2025Mar 13, 2025 ↗View →
ZYME
ZYMEWORKS INC.
PURCHASE
320,690$11.49$3.69M16,040,851Mar 11, 2025Mar 13, 2025 ↗View →
ANAB
ANAPTYSBIO, INC
PURCHASE
6,646$12.95$86.1K7,880,094Jan 2, 2025Jan 2, 2025 ↗View →
ANAB
ANAPTYSBIO, INC
PURCHASE
13,268$12.93$171.5K7,873,448Dec 31, 2024Jan 2, 2025 ↗View →
ANAB
ANAPTYSBIO, INC
PURCHASE
65,184$12.92$842.1K7,860,180Dec 30, 2024Jan 2, 2025 ↗View →
NUVB
NUVATION BIO INC.
PURCHASE
53,000$1.36$72.1K12,674,775Sep 21, 2023Sep 22, 2023 ↗View →
NUVB
NUVATION BIO INC.
PURCHASE
117,100$1.36$159.5K12,621,775Sep 20, 2023Sep 22, 2023 ↗View →
NUVB
NUVATION BIO INC.
PURCHASE
5,143,000$1.26$6.46M12,504,675Sep 19, 2023Sep 22, 2023 ↗View →
NUVB
NUVATION BIO INC.
PURCHASE
53,000$1.36$72.1K12,674,775Feb 21, 2023Sep 21, 2023 ↗View →
NUVB
NUVATION BIO INC.
PURCHASE
117,100$1.36$159.5K12,621,775Feb 20, 2023Sep 21, 2023 ↗View →
NUVB
NUVATION BIO INC.
PURCHASE
5,143,000$1.26$6.46M12,504,675Feb 19, 2023Sep 21, 2023 ↗View →
ANAB
ANAPTYSBIO, INC
SALE
668,237$21.63$14.45M7,521,024May 5, 2022May 6, 2022 ↗View →
ANAB
ANAPTYSBIO, INC
PURCHASE
668,237$21.63$14.45M7,521,024May 5, 2022May 6, 2022 ↗View →
NUVB
NUVATION BIO INC.
PURCHASE
163,268$7.69$1.25M7,361,675Nov 24, 2021Nov 30, 2021 ↗View →
NUVB
NUVATION BIO INC.
PURCHASE
21,758$7.69$167.2K1,169,241Nov 24, 2021Nov 30, 2021 ↗View →
NUVB
NUVATION BIO INC.
PURCHASEGRANT
Stock grant
45,229——45,229Oct 29, 2021Nov 2, 2021 ↗View →
NUVB
NUVATION BIO INC.
PURCHASE
56,598$8.64$489.0K7,198,407Jul 31, 2021Nov 30, 2021 ↗View →
NUVB
NUVATION BIO INC.
SALE
56,598$8.64$489.0K1,147,483Jul 31, 2021Nov 30, 2021 ↗View →
ANAB
ANAPTYSBIO, INC
PURCHASE
165,000$23.25$3.84M7,520,424May 4, 2021May 4, 2021 ↗View →
ANAB
ANAPTYSBIO, INC
PURCHASE
20,800$23.31$484.9K7,355,424May 3, 2021May 4, 2021 ↗View →
ANAB
ANAPTYSBIO, INC
PURCHASE
35,700$23.16$826.8K7,334,624Apr 30, 2021May 4, 2021 ↗View →
ANAB
ANAPTYSBIO, INC
PURCHASE
33,800$23.82$805.1K7,298,924Apr 27, 2021Apr 27, 2021 ↗View →
ANAB
ANAPTYSBIO, INC
PURCHASE
13,900$23.80$330.9K7,265,124Apr 26, 2021Apr 27, 2021 ↗View →
ANAB
ANAPTYSBIO, INC
PURCHASE
99,600$23.54$2.34M7,251,224Apr 23, 2021Apr 27, 2021 ↗View →
NUVB
NUVATION BIO INC.
PURCHASE
27,534$10.27$282.8K6,990,265Apr 13, 2021Apr 13, 2021 ↗View →
NUVB
NUVATION BIO INC.
PURCHASE
3,966$10.27$40.7K1,355,625Apr 13, 2021Apr 13, 2021 ↗View →
NUVB
NUVATION BIO INC.
PURCHASE
16,745$9.49$158.9K1,351,659Apr 12, 2021Apr 13, 2021 ↗View →
NUVB
NUVATION BIO INC.
PURCHASE
116,255$9.49$1.10M6,962,731Apr 12, 2021Apr 13, 2021 ↗View →
NUVB
NUVATION BIO INC.
PURCHASE
37,770$10.03$378.9K1,334,914Apr 9, 2021Apr 13, 2021 ↗View →
NUVB
NUVATION BIO INC.
PURCHASE
262,230$10.03$2.63M6,846,476Apr 9, 2021Apr 13, 2021 ↗View →
NUVB
NUVATION BIO INC.
PURCHASE
151,544$10.45$1.58M1,145,600Mar 31, 2021Nov 30, 2021 ↗View →
NUVB
NUVATION BIO INC.
PURCHASE
151,544$10.45$1.58M6,735,790Mar 31, 2021Nov 30, 2021 ↗View →
NUVB
NUVATION BIO INC.
PURCHASEGRANT
Stock grant
130,000——130,000Feb 10, 2021Feb 12, 2021 ↗View →
NUVB
NUVATION BIO INC.
PURCHASEGRANT
Stock grant
515,879——1,297,144Feb 10, 2021Feb 12, 2021 ↗View →
NUVB
NUVATION BIO INC.
PURCHASEGRANT
Stock grant
387,265$10.00$3.87M781,265Feb 10, 2021Feb 12, 2021 ↗View →
NUVB
NUVATION BIO INC.
PURCHASEGRANT
Stock grant
702,000——702,000Feb 10, 2021Feb 12, 2021 ↗View →
NUVB
NUVATION BIO INC.
PURCHASEGRANT
Stock grant
2,112,735$10.00$21.13M4,218,735Feb 10, 2021Feb 12, 2021 ↗View →
NUVB
NUVATION BIO INC.
PURCHASEGRANT
Stock grant
131,333——131,333Feb 10, 2021Feb 12, 2021 ↗View →
NUVB
NUVATION BIO INC.
PURCHASEGRANT
Stock grant
2,200,627——2,200,627Feb 10, 2021Feb 12, 2021 ↗View →
NUVB
NUVATION BIO INC.
PURCHASEGRANT
Stock grant
394,000——394,000Feb 10, 2021Feb 12, 2021 ↗View →
NUVB
NUVATION BIO INC.
PURCHASEGRANT
Stock grant
2,365,511——6,584,246Feb 10, 2021Feb 12, 2021 ↗View →
NUVB
NUVATION BIO INC.
PURCHASE
2,775,000——3,165,000Feb 10, 2021Feb 12, 2021 ↗View →
NUVB
NUVATION BIO INC.
SALE
2,775,000——0Feb 10, 2021Feb 12, 2021 ↗View →
NUVB
NUVATION BIO INC.
PURCHASEGRANT
Stock grant
2,106,000——2,106,000Feb 10, 2021Feb 12, 2021 ↗View →
Other insiders · NUVB
Loading peer insiders…
About this filer
CIK 0001454385
ROLE
Director
PRIMARY
NUVB
COMPANIES
4
ACTIVE SINCE
Feb 2021
MARKETPEEL · /INSIDER/0001454385DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback